cemiplimab
sanofi,regeneron
['cemiplimab', 'libtayo', '$regn', 'regeneron']
#regeneron reported positive #neoadjuvant #libtayo (#cemiplimab) #monotherapy data in resectable #cutaneous #squamouscellcarcinoma presented at #esmo22 and published in #nejm $regn 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.